Medical Condition News

RSS

FDA-approved 'safe' daily BPA exposure may contribute to insulin resistance

In a first study of its kind study, researchers have found that a common chemical consumers are exposed to several times a day may be altering insulin release.

17 Sep 2018

Study shows cost-effectiveness of financial incentive program to control cholesterol

A program that offered financial incentives to both patients and their physicians to control low-density lipoproteins cholesterol could be a cost-effective intervention for patients at high risk of cardiovascular disease, according to new research led by Harvard T.H. Chan School of Public Health.

14 Sep 2018

People with asthma more likely to become obese, study shows

Obesity is known to be a risk factor for developing asthma but a new study shows that the reverse is also true: people with asthma are more likely to go on to become obese.

14 Sep 2018

Kessler Foundation joins new study to improve cognition in people with progressive MS

Nancy Chiaravalloti, PhD, and John DeLuca, PhD, have been awarded a $410,000 grant from the Multiple Sclerosis Society of Canada and the MS Scientific ResearchFoundation to assess the efficacy of a mixed-method intervention to improve cognition in people with progressive MS.

14 Sep 2018

Case Western Reserve professor wins $2 million grant to study colorectal cancer

Lan Zhou, MD, PhD, associate professor of pathology at Case Western Reserve University School of Medicine, has received a five-year, $2 million grant from the National Cancer Institute of the National Institutes of Health to study human colorectal cancer.

14 Sep 2018

New device to treat acute coronary artery perforations approved by FDA

The U.S. Food and Drug Administration today approved a device intended to treat acute coronary artery perforations, or tears in the blood vessels of the heart. The PK Papyrus Covered Coronary Stent System is the first device approved by the FDA for this indication in 17 years.

14 Sep 2018

Probiotics could reduce the need for antibiotics

A startling new study has found that regular use of probiotics in infancy can significantly reduce antibiotic prescriptions during childhood.

14 Sep 2018

Calorie dense, nutrient deficient meals common across the world

A new study has shown that although we have a good supply of calorie-rich foods, most people are lacking several micronutrients in their diet.

14 Sep 2018

Researchers identify a new cause of chronic stress in the brain

In an international collaboration between MedUni Vienna, Semmelweis University in Budapest, the Karolinska Institute in Stockholm and Yale University in the USA, researchers have identified a new process in the brain that is responsible for the delayed stress response and the long-term effects of stress: with a delay of 10 minutes after the "danger", the area of the brain that reacts to stress and responsible for further action is activated via the cerebral fluid.

14 Sep 2018

Most parents aren't able to recognize meningitis until it's too late

New research commissioned by GSK has shown that the majority of parents incorrectly think that a rash or stiff neck are the first signs of meningitis.

14 Sep 2018

Hemidystrophic Thorax may lead to significant rib humps that mimic scoliosis

Pectus Excavatum (PE), Pectus Carinatum (PC), Poland Syndrome (PS), Sunken Chest Deformity (SCD), Barrel Chest Deformity (BCD), Body Builder Deformity (BBD), and Long Upper Chest Wall (LCW) are Chest Wall Deformities (CWDs) that are documented in the medical literature.

14 Sep 2018

Previously unknown virus acts as 'driver' for interstitial nephropathy

An international research team led by Wolfgang Weninger, who has been Head of MedUni Vienna's Department of Dermatology since 1 September, has discovered a previously unknown virus that acts as a "driver" for certain kidney diseases (interstitial nephropathy).

14 Sep 2018

FDA approves new treatment for people with hairy cell leukemia

AstraZeneca and MedImmune, its global biologics research and development arm, announced today that the US Food and Drug Administration has approved LUMOXITI (moxetumomab pasudotox-tdfk) for the treatment of adult patients with relapsed or refractory hairy cell leukemia who have received at least two prior systemic therapies, including treatment with a purine nucleoside analog.

14 Sep 2018

Caspase-2 enzyme inhibitor could provide effective way to stop aggressive fatty liver disease

Researchers at University of California San Diego School of Medicine have discovered using mice and human clinical specimens, that caspase-2, a protein-cleaving enzyme, is a critical driver of non-alcoholic steatohepatitis, a chronic and aggressive liver condition.

14 Sep 2018